Comparison between Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) Measurement in the Diagnosis of Growth Hormone Deficiency

Endocrine Journal

Volumn 40, Issue 2, 1993, Pages 185-190

  Hasegawa, Yukihiro ^a   Hasegawa, Tomonobu ^a   Aso, Taiji ^a   Kotoh, Shinobu ^a   Tsuchiya, Yutaka ^a   Horie, Hitoshi ^a   Nose, Osamu ^b   Ohyama, Yoshihide ^c   Araki, Kumiko ^d   Tanaka, Toshiaki ^e   Saisyo, Sumitaka ^f   Yokoya, Susumu ^g   Nishi, Yoshikazu ^h   Miyamoto, Shigeki ⁱ   Sasaki, Nozomu ⁱ   Kurimoto, Fumihiko ^j   Toyama, Miyuki ^j   Harada, Akemi ^j   Stene, Mark ^k  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b Nose Clinic   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e NATIONAL CHILDREN S HOSPITAL   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g TORANOMON HOSPITAL   (Japan)

^h ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

ⁱ CHIBA CHILDREN'S HOSPITAL   (Japan)

^j LSI MEDIENCE CORPORATION   (Japan)

^k Endocrine Sciences   (United States)

more..

Author keywords

GH; GH deficiency (GHD); IGF I; IGFBP 3; Normal short children (NS)

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BODY HEIGHT; CARRIER PROTEINS; CHILD; COMPARATIVE STUDY; FEMALE; GROWTH HORMONE; HUMAN; INFANT; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; MALE; RADIOIMMUNOASSAY; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T;

EID: 0027267675     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.40.185     Document Type: Article

References (22)

1. Nissley S, Rechler M (1985) Insulin-like growth factors: biosynthesis, receptors, and carrier proteins. In: Li CH (ed) Hormonal Proteins and Peptides XII. Academic Press, New York, 128-203.
2. Daughaday W, Rotwein P (1989) Insulin-like growth factors I and II. Peptides, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endo Reviews 10: 68-91.
3. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De Leon DD, Donovon SM, Ocrant I, Giudice L (1991) Insulin-like growth factor binding proteins. Rec Prog Horm Res 46: 99-117.
4. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Bouc YL, Povoa G, Merimee TJ, Hossenlopp MP, Binoux M (1989) Molecular forms of serum insulin-like growth factor binding proteins in man: Relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 69: 1291-1301.
5. Hintz R, Liu F, Rosenfeld R, Kemp S (1981) Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab 53: 100-104.
6. Rosenbloom AL, Aguirre JG, Rosenfeld RG, Fielder PJ (1990) The little women of Loja-Growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 323: 1367-1374.
7. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR (1990) A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70: 1292-1298.
8. Martha PM, Reiter EO, Blizzard RM, Stene M, Veldhuis JD and Rogol AD (1991) The maturity-related rise of IGFBP-3 concentration. Pediatric Research 473: 81A (Abstract).
9. Phillip M, Chalew SA, Kowarski AA, Stene M (1991) Insulin-like growth factor binding protein-3 concentrations in poorly growing children. The Endocrine Society 145: 460 (Abstract).
10. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG (1991) Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol [Copenh] 124: 74-85.
11. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y, Kurimoto F (1992) Western Ligand Blot-assay for human growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3)-The serum levels in patients with classical growth hormone deficiency. Endocrinol Japon 39 (1): 121-127.
12. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, Nishi Y, Miyamoto S, Sasaki N, Stene M (1992) Usefulness and limitation of measurement of IGFBP-3 for diagnosis of growth hormone deficiency. Endocrinol Japon 39: 585-591.
13. Hasegawa Y (1992) IGFBP-3 measurements in the diagnosis of growth hormone deficiency and comparison of them with IGF-I measurements. Clinical Pediatric Endocrinology (In press).
14. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, Nishi Y, Miyamoto S, Sasaki N, Harada A, Hone H (1992) Usefulness of IGF-I measurements (after acid extraction) for diagnosis of growth hormone deficiency. Horumon-to-Rinsyou 49(10): 1107-1110 (In Japanese).
15. Toyama M, Kurimoto F, Hasegawa Y, Hasegawa T, Tsuchiya Y (1992) Methodology of IGFBP-3 RIA. Horumon-to-Rinsyou 40(10): 1085-1090 (In Japanese).
16. Blum WF, Ranke MB (1991) Plasma IGFBP-3 levels as clinical indicators. In: Spencer EM (ed) Modern Concepts of Insulin-like Growth Factors. Tokyo 381-393.
17. Hasegawa Y, Hasegawa T, Kotoh S, Tsuchiya Y (1992) False positive ratios of GH provocation tests (arginine and insulin) in control and normal short children. Clinical Pediatric Endocrinology (In press).
18. Hasegawa Y, Hasegawa T, Kotoh S, Tsuchiya Y (1992) Reproducibility of GH provocation tests (arginine and insulin), IGF-I levels and IGFBP-3 levels. Clinical Pediatric Endocrinology (In press).
19. Donaldson DL, Pan F, Hollowell JG, Stevenson JL, Gifford RA, and Moore WV (1991) Reliability of stimulated and spontaneous growth hormone (GH) levels for identifying the child with low GH secretion. J Clin Endocrinol Metab 72: 647-652.
20. Zadik Z, Chalew SA, Kowarski AA (1990) Reproducibility of growth hormone testing procedures: A comparison between 24-hour integrated concentration and pharmcological stimualtion. J Clin Endocrinol Metab 71: 1127-1130.
21. Blum W (1992) Biochemical analysis of IGF-I treatment for GH receptor dysfunction. Acta Pediatr Suppl 383: 125-126.
22. Rosenfeld RG (1992) Biochemical analysis of IGF-I treatment for GH receptor dysfunction. 1st international meeting of GH receptor dysfunction (Abstract).